| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Krystal Biotech IncKRYS | +167.37% | $139.01 | $371.67 | 2025-07-01 - 2026-06-30 | Strong Buy |
Dianthus Therapeutics IncDNTH | +163.61% | $38.88 | $102.49 | 2025-09-17 - 2026-09-16 | Strong Buy |
Merus NvMRUS | +129.26% | $21.94 | $50.30 | 2023-11-02 - 2024-11-01 | Strong Buy |
Korro Bio IncKRRO | +21.37% | $11.70 | $14.20 | 2026-02-19 - 2026-10-29 | Strong Buy |
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Dianthus Therapeutics IncDNTH | 2 | Strong Buy | $130.00 | +57.19% | Maintains | 8 months ago |
Ocular Therapeutix IncOCUL | 1 | Strong Buy | $28.00 | +283.04% | Maintains | 8 months ago |
Korro Bio IncKRRO | 2 | Strong Buy | $18.00 | +26.76% | Upgrades | 8 months ago |
Caribou Biosciences IncCRBU | 1 | Strong Buy | $13.00 | +2,821.35% | Initiates Coverage On | 9 months ago |
Cellectis SaCLLS | 1 | Strong Buy | $9.00 | +669.23% | Initiates Coverage On | 10 months ago |
Wave Life Sciences IncWVE | 2 | Strong Buy | $47.00 | +1,194.77% | Maintains | a year ago |
Annexon IncANNX | 1 | Strong Buy | $17.00 | +323.94% | Initiates Coverage On | a year ago |
Y Mabs Therapeutics IncYMAB | 3 | Hold | $8.60 | N/A | Downgrades | a year ago |
Krystal Biotech IncKRYS | 1 | Strong Buy | $190.00 | N/A | Initiates Coverage On | a year ago |
Crispr Therapeutics AgCRSP | 1 | Hold | $45.00 | N/A | Downgrades | a year ago |
Nkarta IncNKTX | 2 | Strong Buy | $15.00 | N/A | Maintains | 2 years ago |
Fate Therapeutics IncFATE | 1 | Strong Buy | $9.00 | N/A | Maintains | 2 years ago |
Immunocore Holdings PLCIMCR | 3 | Hold | $67.00 | N/A | Maintains | 2 years ago |
Moderna IncMRNA | 3 | Hold | $106.00 | N/A | Maintains | 2 years ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | $24.00 | N/A | Maintains | 3 years ago |
Bicycle Therapeutics PLCBCYC | 1 | Strong Buy | $60.00 | N/A | Reiterates | 3 years ago |
Merus NvMRUS | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 3 years ago |